Physician profile
Bernard E Oakley
NPI 1356353874
$924.56
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $158 · 2021: $42.95 · 2022: $47.86.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $159.79 | 2019 | |
| Pfizer INC. | $105.37 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $79.54 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $66.34 | 2019-2020 | |
| Abbott Laboratories | $65.71 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $65.66 | 2019 | |
| Abbvie INC. | $55.00 | 2019-2020 | |
| Sanofi Pasteur INC. | $53.12 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.85 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $40.27 | 2019-2020 | |
| Astellas Pharma US INC | $37.90 | 2019 | |
| Merck Sharp & Dohme LLC | $37.54 | 2019-2020 | |
| Lilly USA, LLC | $36.03 | 2019 | |
| Amarin Pharma, INC. | $22.84 | 2020 | |
| Novo Nordisk INC | $22.44 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21.48 | 2019 | |
| Allergan, INC. | $14.68 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Oakley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.